Last updated on December 2018

Dose Range Finding Study of Bimagrumab in Sarcopenia

Brief description of study

The purpose of this study is to determine the efficacy of repeat dosing with multiple dose levels of bimagrumab on patient physical function, skeletal muscle mass and strength in older adults with sarcopenia. In addition, this study will generate data on the safety, tolerability, and pharmacokinetics of bimagrumab in older adults with sarcopenia.

Clinical Study Identifier: NCT02333331

Contact Investigators or Research Sites near you

Start Over

Novartis Investigative Site

Kiyose-city, Japan

Novartis Investigative Site

Musashimurayama-city, Japan

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.